Elanco Animal Health (ELAN) Total Liabilities (2017 - 2026)
Elanco Animal Health (ELAN) reported Total Liabilities of $6.7 billion for Q1 2026, up 2.03% on a YoY basis from $6.6 billion in Q1 2025, and down 1.31% sequentially from $6.8 billion in Q4 2025.
Elanco Animal Health (ELAN) Total Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Total Liabilities data on file, last reported at $6.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 2.03% year-over-year to $6.7 billion; the trailing twelve-month figure through Mar 2026 stood at $6.7 billion (up 2.03% YoY), and the FY2025 full-year result was $6.8 billion, up 4.5% from the prior year.
- Total Liabilities fell to $6.7 billion in Q1 2026, from $6.8 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $8.6 billion in Q1 2022 to a low of $49.0 million in Q2 2022.
- A 5-year average of $7.1 billion and a median of $7.8 billion in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities plunged 99.45% in 2022 and jumped 16993.88% in 2023, its largest moves.
- Tracing ELAN's Total Liabilities over 5 years: stood at $8.2 billion in 2022, then slipped by 0.77% to $8.1 billion in 2023, then decreased by 19.92% to $6.5 billion in 2024, then gained by 4.5% to $6.8 billion in 2025, then declined by 1.31% to $6.7 billion in 2026.
- Business Quant data shows ELAN's Total Liabilities at $6.7 billion in Q1 2026, $6.8 billion in Q4 2025, and $6.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 634.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.72 Bn |
| Dec 31, 2025 | 6.81 Bn |
| Sep 30, 2025 | 6.80 Bn |
| Jun 30, 2025 | 6.97 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.52 Bn |
| Sep 30, 2024 | 6.76 Bn |
| Jun 30, 2024 | 7.82 Bn |
| Mar 31, 2024 | 7.96 Bn |
| Dec 31, 2023 | 8.14 Bn |
| Sep 30, 2023 | 8.21 Bn |
| Jun 30, 2023 | 8.38 Bn |
| Mar 31, 2023 | 8.29 Bn |
| Dec 31, 2022 | 8.20 Bn |
| Sep 30, 2022 | 8.20 Bn |
| Jun 30, 2022 | 49.00 Mn |
| Mar 31, 2022 | 8.64 Bn |
| Dec 31, 2021 | 8.97 Bn |
| Sep 30, 2021 | 8.88 Bn |
| Jun 30, 2021 | 8.85 Bn |